Skipper L - Search Results

1

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.

Skipper L, Li Y, Bonnard C, Pavanni R, Yih Y, Chua E, Sung WK, Tan L, Wong MC, Tan EK, Liu J. Skipper L, et al. Hum Mol Genet. 2005 Dec 1;14(23):3549-56. doi: 10.1093/hmg/ddi376. Epub 2005 Nov 3. Hum Mol Genet. 2005. PMID: 16269443

2

Pathogenic mutations in Parkinson disease.

Tan EK, Skipper LM. Tan EK, et al. Hum Mutat. 2007 Jul;28(7):641-53. doi: 10.1002/humu.20507. Hum Mutat. 2007. PMID: 17385668 Review.

3

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

Tan EK, Shen H, Tan LC, Farrer M, Yew K, Chua E, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yih Y, Skipper L, Liu JJ. Tan EK, et al. Among authors: skipper l. Neurosci Lett. 2005 Aug 26;384(3):327-9. doi: 10.1016/j.neulet.2005.04.103. Neurosci Lett. 2005. PMID: 15955629 Clinical Trial.

4

Analysis of LRRK2 functional domains in nondominant Parkinson disease.

Skipper L, Shen H, Chua E, Bonnard C, Kolatkar P, Tan LC, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yuen Y, Farrer M, Liu JJ, Tan EK. Skipper L, et al. Neurology. 2005 Oct 25;65(8):1319-21. doi: 10.1212/01.wnl.0000180517.70572.37. Neurology. 2005. PMID: 16247070

5

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y, Tan L, Pavanni R, Wong MC, Kolatkar P, Lu CS, Bonifati V, Liu JJ. Tan EK, et al. Among authors: skipper l. Hum Genet. 2007 Feb;120(6):857-63. doi: 10.1007/s00439-006-0268-0. Epub 2006 Sep 30. Hum Genet. 2007. PMID: 17019612

6

Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.

Tan EK, Skipper L, Chua E, Wong MC, Pavanni R, Bonnard C, Kolatkar P, Liu JJ. Tan EK, et al. Among authors: skipper l. Mov Disord. 2006 Jul;21(7):997-1001. doi: 10.1002/mds.20875. Mov Disord. 2006. PMID: 16602113

7

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.

Skipper L, Liu JJ, Tan EK. Skipper L, et al. Expert Opin Pharmacother. 2006 May;7(7):849-55. doi: 10.1517/14656566.7.7.849. Expert Opin Pharmacother. 2006. PMID: 16634708 Review.

8

LRRK2 G2019S founder haplotype in the Chinese population.

Tan EK, Skipper L, Tan L, Liu JJ. Tan EK, et al. Among authors: skipper l. Mov Disord. 2007 Jan;22(1):105-7. doi: 10.1002/mds.21206. Mov Disord. 2007. PMID: 17083102

9

Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M. Skipper L, et al. Am J Hum Genet. 2004 Oct;75(4):669-77. doi: 10.1086/424492. Epub 2004 Aug 3. Am J Hum Genet. 2004. PMID: 15297935 Free PMC article.

10

Fine-mapping and candidate gene investigation within the PARK10 locus.

Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Haugarvoll K, et al. Among authors: skipper l. Eur J Hum Genet. 2009 Mar;17(3):336-43. doi: 10.1038/ejhg.2008.187. Epub 2008 Oct 15. Eur J Hum Genet. 2009. PMID: 18854859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page